{
    "ticker": "ADPV",
    "name": "Adaptive Biotechnologies Corp.",
    "description": "Adaptive Biotechnologies Corp. is a biotechnology company based in Seattle, Washington, that focuses on the development of innovative immune-driven medicines. Founded in 2009 by Chad Robins and Harlan Robins, the company aims to harness the power of the adaptive immune system to change the way diseases are diagnosed and treated. Adaptive Biotechnologies is best known for its groundbreaking work in the field of immunology, particularly its proprietary technology platform that decodes the immune repertoire, enabling the identification and characterization of immune responses. The company's flagship products include the clonoSEQ assay, which is used for the detection of minimal residual disease in blood cancers, and various applications in oncology, autoimmune diseases, and infectious diseases. With a strong emphasis on research and collaboration, Adaptive Biotechnologies partners with leading pharmaceutical companies and academic institutions to advance the understanding of the immune system and to develop novel therapies. The company is committed to improving patient outcomes through precision medicine and aims to transform the future of diagnostics and therapeutics.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "Seattle, Washington, USA",
    "founded": "2009",
    "website": "https://www.adaptivebiotech.com",
    "ceo": "Chad Robins",
    "social_media": {
        "twitter": "https://twitter.com/adaptivebiotech",
        "linkedin": "https://www.linkedin.com/company/adaptive-biotechnologies/"
    },
    "investor_relations": "https://investors.adaptivebiotech.com",
    "key_executives": [
        {
            "name": "Chad Robins",
            "position": "CEO"
        },
        {
            "name": "Harlan Robins",
            "position": "Co-Founder and Chief Scientific Officer"
        },
        {
            "name": "Samantha S. Barlow",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Diagnostics",
            "products": [
                "clonoSEQ",
                "TCR Sequencing"
            ]
        },
        {
            "category": "Therapeutics",
            "products": [
                "Immune-driven therapies"
            ]
        }
    ],
    "seo": {
        "meta_title": "Adaptive Biotechnologies Corp. | Innovating Immune-driven Medicines",
        "meta_description": "Explore Adaptive Biotechnologies Corp., a leader in biotechnology focused on immune-driven diagnostics and therapeutics. Learn about their innovative products and mission to transform healthcare.",
        "keywords": [
            "Adaptive Biotechnologies",
            "Biotechnology",
            "Diagnostics",
            "Immunology",
            "Precision Medicine",
            "clonoSEQ"
        ]
    },
    "faq": [
        {
            "question": "What does Adaptive Biotechnologies do?",
            "answer": "Adaptive Biotechnologies develops innovative immune-driven medicines and diagnostic assays to improve patient outcomes."
        },
        {
            "question": "What is clonoSEQ?",
            "answer": "clonoSEQ is a diagnostic assay developed by Adaptive for the detection of minimal residual disease in blood cancers."
        },
        {
            "question": "Who is the CEO of Adaptive Biotechnologies?",
            "answer": "Chad Robins is the CEO of Adaptive Biotechnologies Corp."
        },
        {
            "question": "Where is Adaptive Biotechnologies headquartered?",
            "answer": "Adaptive Biotechnologies is headquartered in Seattle, Washington, USA."
        },
        {
            "question": "When was Adaptive Biotechnologies founded?",
            "answer": "Adaptive Biotechnologies was founded in 2009."
        }
    ],
    "competitors": [
        "NVTA",
        "BLUE",
        "TWST"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX",
        "BMY"
    ]
}